Generation of a human induced pluripotent stem cell line overexpressing CCL22 with islet cells differentiation potential

Stem Cell Res. 2024 Mar:75:103302. doi: 10.1016/j.scr.2023.103302. Epub 2024 Jan 5.

Abstract

CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis, playing an important role in homeostatic and inflammatory responses. A CCL22-overexpressing human induced pluripotent stem cell line (CNNDi001-A-2) was generated by lentiviral transduction to further study the function of CCL22. The cell line was confirmed to have normal proliferation and pluripotency and could be further differentiated into islet cells for cell replacement therapy in diabetes.

MeSH terms

  • Cell Line
  • Chemokine CCL22 / genetics
  • Chemokine CCL22 / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Islets of Langerhans*
  • T-Lymphocytes, Regulatory / metabolism

Substances

  • Chemokine CCL22
  • CCL22 protein, human